プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. ASWANI T.に依頼

India

PhD Biotechnologist, Microbial Research, Bioactive Compounds & Scientific Consulting.

プロフィール概要

I am a Biotechnology PhD with over 7 years of experience in microbiology, microbial biotechnology, and bioactive compound research. My expertise includes microbial isolation, antimicrobial screening, metabolite extraction, and bioprospecting of therapeutically relevant compounds. I also have experience in molecular docking and basic bioinformatics-based data interpretation. Alongside research, I work on sustainable product development, focusing on converting microbial and natural resources into eco-friendly, value-added applications. I offer services in scientific writing, literature review, and research consulting, delivering clear, accurate, and publication-ready outputs tailored to client needs. I am committed to high-quality, timely delivery and welcome collaborative research and innovation-focused projects.

専門分野

• ☆ Drug Discovery
• ☆ High Throughput Screening (HTS)
• ☆ Drug Target Identification
• ☆ Drug Development
• ☆ Drug Substance Characterization
• ☆ Microbiology Testing
• ☆ Drug Stability Testing
• ☆ Preclinical ADME/PK/PD
• ☆ Drug-Drug Interactions
• ☆ Pharmacogenomics
• ☆ In vitro Preclinical Toxciology
• ☆ Drug Efficacy Testing
• ☆ Antibiotic Development
• ☆ Bioavailability
• ☆ Peer Review
• ☆ Research Methodology
• ☆ Literature Search
• ☆ Technical & Scientific Writing
• ☆ Journal Selection
• ☆ Manuscript & Journal Article Writing
• ☆ Experimental Protocols
• ☆ Textbook Content Writing
• ☆ Science Communication

サービス

• Writing
• Research

Writing Technical Writing

Research Scientific and Technical Research, Systematic Literature Review

職務経験

Carbon mannequins

- 現在

sustanable product designer

Carbon mannequins

10月 2025 - 現在

AI Research Scientist

Basesolve

9月 2024 - 10月 2025

Assisitant Professor

REVA University

7月 2022 - 9月 2024

学歴

Ph.D-Biotechnology

National Institute of Technology Calicut

1月 2016 - 11月 2021

認定資格

• course completion

  Nitc

  https://drive.google.com/file/d/1rM7sL9w2QpgdzkFT80q2pqGekCDJVZ7r/view?usp=sharing

  9月 2021 - 現在

出版物

BOOK CHAPTER

ASWANI THEKKANGIL (2023). OCD: Current Diagnostic and Treatment Challenges. Nutrition and Obsessive-Compulsive Disorder.

ASWANI THEKKANGIL (2023). Recent advancement in microbial remediation of heavy metals from industrial effluents . Clean Technologies Toward the Development of a Sustainable Environment and Future.

(2019). Actinomycetes: Its Realm in Nanotechnology . Nanotechnology in the Life Sciences.

JOURNAL ARTICLE

(2020). Antidermatophytic lead compounds from Streptomycetes albidoflavus STV1572a against Tinea infections by Tricophyton mentagrophytes. Microbial Pathogenesis.

(2019). Characterization and antifungal activity of the yellow pigment produced by a Bacillussp. DBS4 isolated from the lichenDirinaria agealita . Saudi Journal of Biological Sciences.

(2019). Water–Chloroform Interface Assisted Microstructure Tuning of Polypyrrole–Silver Sheets . ACS Applied Materials & Interfaces.

(2013). • Comparative analysis of anti-coagulant potential of marine macro algae. International Journal of Pharmacy and Pharmaceutical Sciences.

CONFERENCE PAPER

(2019). Screening of wetland soil actinomycetes for natural pigment:extraction and characterization studies. ICHTR-2019.

(2018). Extraction of antidermatophytic compound from Streptomyces sp.: An antidote for Tinea infection caused by Tricophyton verricosum. Biogenesis -The journal of Biology and Medicine.

(2016). RAPID IDENTIFICATION OF STREPTOMYCES ISOLATES BY MATRIX ASSISTED LASER DESORPTION IONIZATION-TIME OF FLIGHT MASS SPECTROMETRY (MALDI-TOF MS).

Pigment production from endolichenic bacteria.

Target Studies of Potential Antibacterial Compounds from Actinomycetes: A Computer Aided Approach.

“Endolichenic Actinomycetes isolated from Dirinaria aegialita (Afzel. ex Ach.) B.J.Moore and Screening of Antimicrobial Components ”.

“Isolation of endolichenic bioactive Streptomyces spp. From Dirinaria aegialita”.

Endolichenic bacteria from Dirinaria Aegialita: Diversity in Distinct Symbionts.

Actinomycetes derived anti-MRSA drugs targeting to PBP2a.